Reaction Details |
| Report a problem with these data |
Target | NADPH oxidase 4 |
---|
Ligand | BDBM50330713 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_685143 (CHEMBL1286959) |
---|
Ki | 328±n/a nM |
---|
Citation | Laleu, B; Gaggini, F; Orchard, M; Fioraso-Cartier, L; Cagnon, L; Houngninou-Molango, S; Gradia, A; Duboux, G; Merlot, C; Heitz, F; Szyndralewiez, C; Page, P First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem53:7715-30 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
NADPH oxidase 4 |
---|
Name: | NADPH oxidase 4 |
Synonyms: | KOX-1 | Kidney oxidase-1 | Kidney superoxide-producing NADPH oxidase | NOX4 | NOX4_HUMAN | RENOX | Renal NAD(P)H-oxidase |
Type: | PROTEIN |
Mol. Mass.: | 66954.54 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_792879 |
Residue: | 578 |
Sequence: | MAVSWRSWLANEGVKHLCLFIWLSMNVLLFWKTFLLYNQGPEYHYLHQMLGLGLCLSRAS
ASVLNLNCSLILLPMCRTLLAYLRGSQKVPSRRTRRLLDKSRTFHITCGVTICIFSGVHV
AAHLVNALNFSVNYSEDFVELNAARYRDEDPRKLLFTTVPGLTGVCMVVVLFLMITASTY
AIRVSNYDIFWYTHNLFFVFYMLLTLHVSGGLLKYQTNLDTHPPGCISLNRTSSQNISLP
EYFSEHFHEPFPEGFSKPAEFTQHKFVKICMEEPRFQANFPQTWLWISGPLCLYCAERLY
RYIRSNKPVTIISVMSHPSDVMEIRMVKENFKARPGQYITLHCPSVSALENHPFTLTMCP
TETKATFGVHLKIVGDWTERFRDLLLPPSSQDSEILPFIQSRNYPKLYIDGPFGSPFEES
LNYEVSLCVAGGIGVTPFASILNTLLDDWKPYKLRRLYFIWVCRDIQSFRWFADLLCMLH
NKFWQENRPDYVNIQLYLSQTDGIQKIIGEKYHALNSRLFIGRPRWKLLFDEIAKYNRGK
TVGVFCCGPNSLSKTLHKLSNQNNSYGTRFEYNKESFS
|
|
|
BDBM50330713 |
---|
n/a |
---|
Name | BDBM50330713 |
Synonyms: | CHEMBL1275631 | N-(3-(4,5-dimethyl-3,6-dioxo-5,6-dihydro-1H-pyrazolo[4,3-c]pyridin-2(3H)-yl)phenyl)acetamide |
Type | Small organic molecule |
Emp. Form. | C16H16N4O3 |
Mol. Mass. | 312.3232 |
SMILES | CC(=O)Nc1cccc(c1)-n1[nH]c2cc(=O)n(C)c(C)c2c1=O |
Structure |
|